Résumé
Background: Dengue viral infections are among the most important mosquito-borne diseases of the Bangladeshi subcontinent and have become a major global public health concern. The spread of the disease has led to increased recognition of atypical manifestations apart from the classical clinical features of dengue infection.This study aimed to provide clinical and biochemical profiles of Bangladesh’s dengue-infected patients.Material & Methods:This cross-sectional study was conducted from January 2021 to December 2021 in different government and private tertiary care hospitals in Dhaka, Bangladesh. We collected information on demographic data, clinical characteristics, and laboratory profiles for 271 confirmed hospitalized acute dengue cases using a structured questionnaire.Results:A total of 271 patients were hospitalized and received treatment for DEVN infection from the respective hospital of our research. Table 1 describes the socio-demographic data of the enrolled patients in the study. As shown in Table-1, out of 271 patients, 164(60.52%) were male and 107(39.48%) were female Almost half of the patients (135(49.82%) were from the age group 20-40 years. Of the 271 patients, around 179(66.05%) patients had a nuclear family and 92(33.95%) patients had a joint family. lab parameters of the blood samples of patients with DENV infection; from the report of leukocyte count, 134(66.01%) patients had >4000/cumm and 69(33.09%) patients had ?4000/cumm. The pattern of seropositivity and clinical diagnostic method of patients with DENV infection of the study population.Conclusions:Over the last couple of years, dengue fever has become a major health issue in Bangladesh. To reduce the burden of this disease, timely diagnosis and prompt treatment are necessary. This analysis thus yields the clinical features, laboratory profiles, and seropositivity test results of dengue patients from Bangladesh. The research results may help clinicians understand the circumstantial diagnosis of dengue patients and facilitate early intervention.
Résumé
Background: The ongoing pandemic COVID-19 is more serious for people with comorbidities and the elderly people. Comorbidities such as hypertension, diabetes, cardiovascular disease, and chronic liver disease affect the majority of COVID-19 patients. COVID-19 affected patients having comorbidities are often admitted to ICU for proper treatment. The aim of this study was to evaluate the impact of co-morbidities on Covid-19 Positive Cases Admitted to ICU. Material & Methods: This cross-sectional study was conducted in the Department of Anesthesia and ICU, Shaheed Sheikh Abu NaserSpecialized Hospital, Khulna, Bangladesh, during the period from June 2020 to July 2021. A total of 87 patients with covid-19 positive admitted to ICU were included in this study.Results:The majority of the study people were in the age group of 60-69. Most of the study people were male in with co-morbidities group (52.87%) and were female in without co-morbidities group (5.75%). Among 87 patients, 78 (89.6%) had different types of co-morbidities. More than half of the study people (64.37%) had diabetes. We found that the majority of the patients (77.30%) stayed in ICU for less than 15 days. 80.95% of patients with hypertension had to stay in ICU for less than 15 days. Among the patients with diabetes, 73.21% stayed in ICU for less than 15 days. About 8.97% of patients with diabetes were discharged from the hospital. 2.56% of patients with hypertension and diabetes were referred to another hospital. Among the death patients, 58.97% had diabetes and 43.59% had hypertension.Conclusions:Patients with comorbidities were more severely affected and had a higher mortality rate. Age, diabetes mellitus, and hypertension were the main factors affecting the survival of patients.